InsiderClue
Stocks · Health care · Pharmaceutical Preparations

TherapeuticsMD, Inc.

TXMD Clue Score41
United States Fiscal year ends December CIK 0000025743
$2.06 +2.49% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.06 +198.25% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 11 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue19.4Operating income−90.3Net income−89.9Fiscal year 2017Revenue16.8 −13.3%Operating income−77.6Net income−76.9Fiscal year 2018Revenue16.1 −4.0%Operating income−130.2Net income−132.6Fiscal year 2019Revenue49.6 +208.4%Operating income−151.2Net income−176.1Fiscal year 2020Revenue64.9 +30.7%Operating income−155.5Net income−183.5Fiscal year 2021Revenue2.6 −96.0%Operating income−79.6Net income−172.4EPS, diluted−21.66Fiscal year 2022Revenue70.0 +2,619.1%Operating income1.2Net income112.0EPS, diluted11.96Fiscal year 2023Revenue1.3 −98.1%Operating income−8.5Net income−10.3 −109.2%EPS, diluted−0.99Fiscal year 2024Revenue1.8 +35.3%Operating income−6.1Net income−2.2EPS, diluted−0.19Fiscal year 2025Revenue3.0 +71.6%Operating income−4.4Net income−0.6EPS, diluted−0.05
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 19.4 16.8 16.1 49.6 64.9 2.6 70.0 1.3 1.8 3.0
Growth −13.3% −4.0% +208.4% +30.7% −96.0% +2,619.1% −98.1% +35.3% +71.6%
Operating income −90.3 −77.6 −130.2 −151.2 −155.5 −79.6 1.2 −8.5 −6.1 −4.4
Net income −89.9 −76.9 −132.6 −176.1 −183.5 −172.4 112.0 −10.3 −2.2 −0.6
Growth −109.2%
EPS, diluted n/a n/a n/a n/a n/a −21.66 11.96 −0.99 −0.19 −0.05

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Gross margin78.4%Operating margin−466.3%Net margin−464.3%Free cash flow margin−359.3%Fiscal year 2017Gross margin84.3%Operating margin−462.7%Net margin−458.5%Free cash flow margin−454.3%Fiscal year 2018Gross margin83.0%Operating margin−808.8%Net margin−823.7%Free cash flow margin−664.8%Fiscal year 2019Gross margin87.2%Operating margin−304.6%Net margin−354.8%Free cash flow margin−338.7%Fiscal year 2020Gross margin75.4%Operating margin−239.8%Net margin−282.9%Free cash flow margin−246.1%Fiscal year 2021Gross margin45.5%Operating margin−3,092.8%Net margin−6,700.9%Free cash flow margin−5,547.1%Fiscal year 2022Gross margin98.0%Operating margin1.7%Net margin160.1%Fiscal year 2023Gross margin100.0%Operating margin−654.6%Net margin−789.4%Fiscal year 2024Operating margin−347.1%Net margin−123.9%Fiscal year 2025Operating margin−145.3%Net margin−18.8%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 78.4% 84.3% 83.0% 87.2% 75.4% 45.5% 98.0% 100.0% n/a n/a
Operating margin −466.3% −462.7% −808.8% −304.6% −239.8% −3,092.8% 1.7% −654.6% −347.1% −145.3%
Net margin −464.3% −458.5% −823.7% −354.8% −282.9% −6,700.9% 160.1% −789.4% −123.9% −18.8%
Free cash flow margin −359.3% −454.3% −664.8% −338.7% −246.1% −5,547.1% n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−69.1Capital expenditure−0.4Free cash flow−69.5Fiscal year 2017Operating cash flow−76.2Capital expenditure−0.1Free cash flow−76.2Fiscal year 2018Operating cash flow−106.8Capital expenditure−0.2Free cash flow−107.0Fiscal year 2019Operating cash flow−165.7Capital expenditure−2.5Free cash flow−168.2Fiscal year 2020Operating cash flow−159.5Capital expenditure−0.2Free cash flow−159.7Fiscal year 2021Operating cash flow−142.7Capital expenditure−0.0Free cash flow−142.7Fiscal year 2022Operating cash flow9.4Fiscal year 2023Operating cash flow−23.1Fiscal year 2024Operating cash flow1.2Fiscal year 2025Operating cash flow2.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −69.1 −76.2 −106.8 −165.7 −159.5 −142.7 9.4 −23.1 1.2 2.5
Capital expenditure −0.4 −0.1 −0.2 −2.5 −0.2 −0.0 n/a n/a n/a n/a
Free cash flow −69.5 −76.2 −107.0 −168.2 −159.7 −142.7 n/a n/a n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash131.5Shareholders’ equity127.5Fiscal year 2017Cash127.1Shareholders’ equity129.9Fiscal year 2018Cash161.6Total debt73.4Net cash (debt)88.2Shareholders’ equity97.5Debt to equity0.75Fiscal year 2019Cash160.8Total debt194.6Net cash (debt)−33.8Shareholders’ equity9.2Debt to equity21.15Fiscal year 2020Cash80.5Total debt237.7Net cash (debt)−157.2Shareholders’ equity−124.0Fiscal year 2021Cash64.9Total debt188.3Net cash (debt)−123.4Shareholders’ equity−93.6Fiscal year 2022Cash49.3Shareholders’ equity35.1Fiscal year 2023Cash4.3Shareholders’ equity29.3Fiscal year 2024Cash5.1Shareholders’ equity27.4Fiscal year 2025Cash7.5Shareholders’ equity26.9
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 131.5 127.1 161.6 160.8 80.5 64.9 49.3 4.3 5.1 7.5
Total debt n/a n/a 73.4 194.6 237.7 188.3 n/a n/a n/a n/a
Net cash (debt) n/a n/a 88.2 −33.8 −157.2 −123.4 n/a n/a n/a n/a
Shareholders’ equity 127.5 129.9 97.5 9.2 −124.0 −93.6 35.1 29.3 27.4 26.9
Debt to equity n/a n/a 0.75 21.15 n/a n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
19.4 16.8 16.1 49.6 64.9 2.6 70.0 1.3 1.8 3.0
Growth −13.3% −4.0% +208.4% +30.7% −96.0% +2,619.1% −98.1% +35.3% +71.6%
4.2 2.6 2.7 6.3 16.0 1.4 1.4 n/a n/a n/a
15.2 14.1 13.4 43.3 48.9 1.2 68.6 1.3 n/a n/a
Growth −6.8% −5.5% +224.1% +12.9% −97.6% +5,755.3% −98.1%
53.9 33.9 27.3 19.8 10.4 7.1 n/a n/a n/a n/a
51.3 57.7 116.0 174.1 193.0 80.7 56.7 8.9 4.7 6.9
−90.3 −77.6 −130.2 −151.2 −155.5 −79.6 1.2 −8.5 −6.1 −4.4
Growth −815.6%
−89.9 −76.9 −132.6 −176.1 −183.5 −79.3 1.1 −7.7 −2.3 −0.7
n/a n/a n/a n/a n/a n/a n/a −0.0 −0.0 n/a
−89.9 −76.9 −132.6 −176.1 −183.5 −172.4 112.0 −10.3 −2.2 −0.6
Growth −109.2%
Per share
n/a n/a n/a n/a n/a −21.66 12.41 −0.99 −0.19 −0.05
n/a n/a n/a n/a n/a −21.66 11.96 −0.99 −0.19 −0.05
Growth −108.3%
n/a n/a n/a 246.4 275.6 8.0 9.0 0.0 11.5 11.6
n/a n/a n/a n/a n/a 8.0 9.4 0.0 11.5 11.6
Growth +17.7% −99.9% +110,349.2% +0.3%

† The diluted share count jumps at 2023 and 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 45.8% a year over five years.
  • Operating margin is up 94.5 points on five years ago, at -145.3%.
  • A net loss in 9 of 10 years on file.